Knowledge and perception among adults of their congenital heart disease: A single center cross-sectional study

2024-9-1

Clinical features and long-term outcomes in patients under 35 years with coronary artery disease: nested case-control study

2024-9-1

Of mice and man

2024-9-1

Not an allergy: Iodine contrast-induced acute sialadenitis after coronary angiography

2024-8-1

Regional myocardial infarction networks: How to improve quality

2024-8-1

Real-world evaluation of vascular complications and comorbidities in Portuguese patients with Type 2 Diabetes: Results from the cMORE study

2024-8-1

Atrial fibrillation ablation in patients with heart failure: Which patients are most likely to respond?

2024-8-1

One more piece for the puzzle of stem cell therapy in cardiovascular diseases

2024-8-1

Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography

2024-8-1

Left ventricular global longitudinal strain is associated with filling pressures and cardiac output in an outpatient setting: Insights from the CardioMEMSTM

2024-8-1

Diagnostic prediction rules in acute pulmonary embolism: Is it acceptable to compromise safety?

2024-8-1

Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats

2024-8-1

Importance and usefulness of SCORE2 in Cardiovascular Prevention

2024-8-1

Sex-related differences in ST-segment elevation myocardial infarction: A Portuguese multicenter national registry analysis

2024-8-1

Dapagliflozin: Improving heart failure outcomes does not necessarily mean increasing costs

2024-8-1

Cardiac arrest: It is important not just to survive, but to survive with at least an acceptable quality of life

2024-8-1

Response to the letter “Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines”

2024-7-1

Real-world evaluation of vascular complications and comorbidities in Portuguese patients with type 2 diabetes: Results from the cMORE study

2024-7-1

Exploring the evidence gap: Loop diuretic withdrawal in chronic heart failure

2024-7-1

The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis

2024-7-1

Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming

2024-7-1

Rare images of a unileaflet mitral valve

2024-7-1

Moderately intense physical exercise alleviates electrocardiographic changes induced by cisplatin in rats

2024-7-1

Early versus late cardiac magnetic resonance in the diagnosis of MINOCA

2024-7-1

Cardiac rehabilitation training in cardiology residency: A missing block in the training program

2024-7-1

The balance between thrombosis and bleeding after mitral valve surgery: The need for robust evidence

2024-7-1

Exercise and Sports revisited: is too much exercise bad for your heart?

2024-7-1

“Observe, simulate, execute and mentor”: a contemporary approach to learning in Interventional Cardiology

2024-7-1

Left atrial appendage thrombus in severe mitral stenosis: Can chamber morphology and thrombus location influence therapeutic choice?

2024-7-1

Initial experience with orbital atherectomy in a non-surgical center in Portugal

2024-7-1

Cardiovascular risk assessment using SCORE2 in a population with hypertension - the reality at a primary health care unit

2024-7-1

Beyond Clinical Trials – The cost-saving associated with dapagliflozin use in portuguese hospital clinical practice

2024-7-1

Heart with Mozambique: A Portuguese contribution to the eradication of rheumatic heart disease

2024-7-1

Enhancing diagnostic yield in MINOCA: The Critical Timing of Cardiac magnetic resonance

2024-7-1

Pulmonary arterial hypertension: Navigating the pathways of progress in diagnosis, treatment, and patient care

2024-7-1

World Heart Federation Cholesterol Roadmap: The Portuguese case

2024-7-1

Mesenchymal stem cells may alleviate angiotensin II-induced myocardial fibrosis and hypertrophy by upregulating SFRS3 expression

2024-7-1

Is the cardiovascular risk SCORE2 globally valid and useful?

2024-6-1

Response to the letter “Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines”

2024-6-1

Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies

2024-6-1

“O meu coração bate saudável” – Results from a pilot project for health education in Portuguese children

2024-6-1

“The challenge of choosing the right prosthesis for the right patient - The devil is in the details”

2024-6-1

Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery

2024-6-1

Polytetrafluoroethylene graft for anomalous left coronary artery from the pulmonary artery: 6-year patency

2024-6-1

Loop diuretic discontinuation in chronic heart failure patients: A retrospective study

2024-6-1

Tuberculous submitral aneurysm: A rare cardiac presentation of a common pathogen

2024-6-1

Cardiac hydatid cysts: Please do not waste time

2024-6-1

Idiopathic ventricular fibrillation: A never ending “clinical” history

2024-5-31

Ventricular tachycardia ablation in non-ischemic cardiomyopathy: A Sisyphean task?

2024-5-31

The bidirectional association between cardiovascular disease and cancer: Is there an increased risk of cancer among heart failure patients?

2024-5-15